Virus and chemo combo takes on hard-to-treat head and neck cancers
NCT ID NCT07398664
First seen Feb 11, 2026 · Last updated Apr 30, 2026 · Updated 7 times
Summary
This study tests a new combination for people with head and neck cancer that has come back or spread after at least two standard treatments. The approach uses a modified virus (H101) plus a targeted chemotherapy delivered directly to the tumor's blood supply (TACE) to kill cancer cells and boost the immune system. About 20 participants will be followed to see if tumors shrink and how long they stay controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.